1 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 1件: 113 💬 |
2 |
Alirocumab sar236553 (regn727) |
Alirocumab |
1件: D10335 D10335 💬 |
PCSK9 1件: PCSK9 💬 |
Cholesterol metabolism 1件: Cholesterol metabolism |
079 1件: 79 💬 |
3 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
6件: D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 3件: OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 1件: 78 💬 |
4 |
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab |
Abatacept |
4件: D02596 D02596, D02994 D02994, D03203 D03203, D10161 D10161 💬 |
CD80 4件: CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection 24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
5 |
Fluoxetine |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 4件: 13, 17, 78, 86 💬 |
6 |
Fluoxetine hydrochloride |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
7 |
Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 1件: 229 💬 |
8 |
Gm-csf [leukine (sargramostim)] |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 1件: 229 💬 |
9 |
Gz/sar402671 |
- |
- |
- |
- |
006 2件: 6 , 19 💬 |
10 |
Gz402671 / sar402671 |
- |
- |
- |
- |
019 1件: 19 💬 |
11 |
Isatuximab |
Isatuximab |
1件: D11050 D11050 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 2件: 28, 61 💬 |
12 |
Isatuximab sar650984 |
Isatuximab |
1件: D11050 D11050 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
061 1件: 61 💬 |
13 |
Lademirsen (sar339375) |
- |
- |
- |
- |
218 1件: 218 💬 |
14 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 1件: 301 💬 |
15 |
Regn475/sar164877 |
- |
- |
- |
- |
298 1件: 298 💬 |
16 |
Sar |
- |
- |
- |
- |
046 1件: 46 💬 |
17 |
Sar100842 |
- |
- |
- |
- |
051 1件: 51 💬 |
18 |
Sar113244 |
- |
- |
- |
- |
049 1件: 49 💬 |
19 |
Sar153191 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 4件: 41, 46, 107, 271 💬 |
20 |
Sar153191 (regn88) |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 107 💬 |
21 |
Sar156597 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
22 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 1件: 51 💬 |
23 |
Sar231893 |
- |
- |
- |
- |
051 2件: 51, 160 💬 |
24 |
Sar236553 |
- |
- |
- |
- |
079 1件: 79 💬 |
25 |
Sar339658 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
26 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 3件: 6 , 19, 67 💬 |
27 |
Sar421869 |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
28 |
Sar422459 |
- |
- |
- |
- |
301 1件: 301 💬 |
29 |
Sar441344 |
- |
- |
- |
- |
053 1件: 53 💬 |
30 |
Sar442168 |
- |
- |
- |
- |
013 1件: 13 💬 |
31 |
Saracatinab |
- |
- |
- |
- |
085 1件: 85 💬 |
32 |
Saracatinib |
Saracatinib |
1件: D09664 D09664 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 3件: 6 , 89, 272 💬 |
33 |
Saracatinib difumarate |
Saracatinib |
1件: D09664 D09664 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
272 1件: 272 💬 |
34 |
Sarcosine |
Sarcosine |
- |
- |
- |
006 1件: 6 💬 |
35 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 1件: 6 💬 |
36 |
Sargramostim |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 7件: 6 , 28, 60, 62, 96, 229, 285 💬 |
37 |
Sargramostim (leukine) |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 1件: 96 💬 |
38 |
Sarilumab |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 5件: 41, 46, 84, 107, 271 💬 |
39 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara] |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
40 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
084 1件: 84 💬 |
41 |
Sarilumab sar153191 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 1件: 41 💬 |
42 |
Sarilumab sar153191 (regn88) |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 107 💬 |
43 |
Sarizotan |
Sarizotan |
- |
- |
- |
006 2件: 6 , 156 💬 |
44 |
Sarizotan hc1 |
Sarizotan |
- |
- |
- |
006 1件: 6 💬 |
45 |
Sarizotan hcl |
Sarizotan |
- |
- |
- |
006 1件: 6 💬 |
46 |
Sarizotan hydrochloride |
Sarizotan |
- |
- |
- |
006 2件: 6 , 156 💬 |
47 |
Saroglitazar |
Saroglitazar |
- |
- |
- |
093 1件: 93 💬 |
48 |
Saroglitazar magnesium 2 mg |
Magnesium |
- |
- |
- |
093 1件: 93 💬 |
49 |
Saroglitazar magnesium 4 mg |
Magnesium |
- |
- |
- |
093 1件: 93 💬 |
50 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
7件: D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR 4件: GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction 9件: Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 1件: 78 💬 |
51 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
52 |
Venglustat (gz/sar402671) |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
53 |
Venglustat gz/sar402671 |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
067 1件: 67 💬 |